文献速递乳房整形与再造

外科医生控制的直接置入假体与两阶段组织扩张器-假体即刻乳房再造结局比较

Surgeon-Controlled Comparison of Direct-to-Implant and 2-Stage Tissue Expander-Implant Immediate Breast Reconstruction Outcomes.
PubMed 文献 · Ann Plast Surg · 2018-01-01

单中心回顾性队列比较2010至2014年即刻乳房再造:组织扩张器组79只乳房(50例),直接置入假体组117只乳房(69例)。组织扩张器组总体并发症、感染率及美学修整率均高于直接置入假体组,血清肿、血肿及乳房切除皮瓣坏死率两组无差异;体重指数大于30者行组织扩张器再造的感染并发症显著高于直接置入假体再造。

要点

  • 组织扩张器组总体并发症、感染率及美学修整率均高于直接置入假体组。
  • 两组血清肿、血肿及乳房切除皮瓣坏死率无差异。
  • 体重指数大于30者组织扩张器再造感染并发症显著高于直接置入假体再造。

核心结论

  • 单阶段直接置入假体即刻乳房再造的总体并发症少于两阶段组织扩张器即刻再造。
  • 直接置入假体即刻乳房再造可能为体重指数大于30的患者提供有利结局。

研究设计与样本

  • 经机构审查委员会批准的单中心回顾性队列研究,纳入2010至2014年连续接受即刻乳房再造的患者。
  • 组织扩张器组79只乳房(50例),直接置入假体组117只乳房(69例);记录人口学数据与并发症,采用单因素分析比较。
  • 感染定义为术后预期疗程外使用抗生素或因疑似感染重新使用抗生素。

主要发现

  • 组织扩张器组总体并发症、感染率及美学修整率均高于直接置入假体组。
  • 两组血清肿、血肿及乳房切除皮瓣坏死率无差异。
  • 体重指数大于30行组织扩张器再造者的感染并发症显著高于行直接置入假体再造者。

临床怎么用

  • 单阶段直接置入假体即刻乳房再造的总体并发症少于两阶段组织扩张器即刻再造。
  • 直接置入假体即刻乳房再造可能为体重指数大于30的患者提供有利结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current literature comparing outcomes of immediate breast reconstruction using direct-to-implant (DTI) single-stage and 2-stage tissue expanders (TEs) is conflicting. This study compared overall outcomes and determined predictive patient factors associated with higher complication rates. METHODS: After institutional review board approval, a retrospective cohort study of consecutive patients who underwent immediate breast reconstruction from 2010 to 2014 at a single hospital was performed. Demographic data and complications were recorded and compared using univariate analysis. Infection was defined as any patient receiving antibiotics beyond the expected postoperative course or restarting antibiotics for a suspected infection. RESULTS: Seventy-nine breasts (50 patients) underwent immediate breast reconstruction using tissue expansion, and 117 breasts (69 patients) underwent immediate breast reconstruction using the DTI technique. Overall complications, infection rate, and rate of aesthetic revisions were higher in the TE group compared with the DTI group. There was no difference in rates of seroma, hematoma, and mastectomy skin flap necrosis between the 2 groups. Infectious complications were significantly higher in patients with body mass index of greater than 30 who underwent TE-based reconstruction than those who underwent DTI-based reconstruction. CONCLUSIONS: Single-stage DTI immediate breast reconstruction has less overall complications than 2-stage TE-based immediate reconstruction. Direct-to-implant immediate breast reconstruction may provide favorable outcomes in patients with body mass index of greater than 30.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Azouz V, Lopez S, Wagner DS, et al. Surgeon-Controlled Comparison of Direct-to-Implant and 2-Stage Tissue Expander-Implant Immediate Breast Reconstruction Outcomes. Ann Plast Surg. 2018. PMID: 28984661. doi:10.1097/SAP.0000000000001220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。